ACTU ACTUATE THERAPEUTICS, INC.: institutional ownership and insider trading
57 funds reported holding $23.7M of ACTUATE THERAPEUTICS, INC. in their latest 13F filings; in Q2 2026 funds net sold $757K, with 15 new positions and 15 funds selling out; over the last 12 months insiders bought $0 and sold $1.62M on the open market.
Famous investors holding ACTU
- Izzy Englander (Millennium Management): $148K, 0.0% of the portfolio
Largest institutional holders of ACTU
- BIOS Capital Management, LP — $15.4M
- VANGUARD GROUP INC — $3.24M
- Voss Capital, LP — $2.64M
- VANGUARD CAPITAL MANAGEMENT LLC — $602K
- AQR CAPITAL MANAGEMENT LLC — $195K
- GEODE CAPITAL MANAGEMENT, LLC — $172K
- Texas Capital Bank Wealth Management Services Inc — $157K
- Palogic Value Management, L.P. — $153K
- MILLENNIUM MANAGEMENT LLC — $148K
- BlackRock, Inc. (BLK) — $138K
Recent ACTU insider trades
- Jan 5, 2026: Thomson Todd S sold 280,000 shares ($1.62M)
- Jun 27, 2025: BP Directors, LP bought 71,428 shares ($500K)
- Jun 27, 2025: BIOS Fund I, LP bought 71,428 shares ($500K)
- Jun 27, 2025: BIOS Actuate Co-Invest I, LP bought 71,428 shares ($500K)
5%+ owners
- Voss Capital, LP: 7.7% (Schedule 13G/A, filed Apr 22, 2026)